for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

USANA Health Sciences, Inc.

USNA.N

Latest Trade

76.34USD

Change

1.87(+2.51%)

Volume

14,253

Today's Range

74.87

 - 

76.40

52 Week Range

58.32

 - 

125.54

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
74.47
Open
74.87
Volume
14,253
3M AVG Volume
3.11
Today's High
76.40
Today's Low
74.87
52 Week High
125.54
52 Week Low
58.32
Shares Out (MIL)
21.64
Market Cap (MIL)
1,609.16
Forward P/E
18.61
Dividend (Yield %)
--

Next Event

Q4 2019 USANA Health Sciences Inc Earnings Release

Latest Developments

More

USANA Health Sciences Posts Q3 EPS Of $1.09

Usana Health Sciences Q2 Earnings Per Share $0.91

USANA Health Sciences Says Entered Into Amendment To Amended & Restated Credit Agreement So Lender May Raise Commitment By $125 Mln On Co's Request

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Industry

Biotechnology & Drugs

Contact Info

3838 W Parkway Blvd

+1.801.9547100

https://www.usana.com/

Executive Leadership

Myron W. Wentz

Chairman of the Board

Jim H. Brown

President

Kevin G. Guest

Chief Executive Officer, Director

G Douglas Hekking

Chief Financial Officer

Walter Noot

Chief Operating Officer

Key Stats

3.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.0K

2017

1.0K

2018

1.2K

2019(E)

1.0K
EPS (USD)

2016

3.990

2017

4.060

2018

5.120

2019(E)

3.995
Price To Earnings (TTM)
17.14
Price To Sales (TTM)
1.48
Price To Book (MRQ)
5.12
Price To Cash Flow (TTM)
13.71
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
26.18
Return on Equity (TTM)
19.22

Latest News

Latest News

BRIEF-Usana Health Sciences Q1 Earnings Per Share $1.19

* USANA HEALTH SCIENCES REPORTS RECORD FIRST QUARTER 2018 NET SALES AND INCREASES 2018 OUTLOOK

BRIEF-Usana Health Sciences Reports Q4 Loss Per Share $0.24

* USANA HEALTH SCIENCES REPORTS RECORD FOURTH QUARTER AND FULL-YEAR 2017 NET SALES

BRIEF-Usana Health Sciences Provides Estimated Impact Of U.S. Tax Reform

* USANA HEALTH SCIENCES PROVIDES ESTIMATED IMPACT OF U.S. TAX REFORM

BRIEF-Usana Health Sciences reports Q3 earnings $0.97/shr

* Usana Health Sciences reports third quarter financial results

BRIEF-Usana says plans to expand in four European countries

* Says it will be expanding in four European countries beginning mid-year 2018

BRIEF-Pollard banknote responds to filing of Innova Gaming Circular

* Pollard Banknote- responded to filing of Innova Gaming Circular in connection with offer of co to buy all common shares of Innova for $2.10 per share

BRIEF-USANA Health Sciences promotes Doug Hekking to CFO

* Appointment of chief executive officer Kevin Guest to company's board of directors

BRIEF-USANA Health Sciences Q1 earnings per share $0.91 excluding items

* USANA Health Sciences reports first quarter financial results

BRIEF-USANA Health Sciences's unit becomes official sponsor of China's General Administration Of Sports Training Bureau

* Unit Babycare Ltd becomes an official sponsor of China's General Administration Of Sports Training Bureau

BRIEF-Usana Health Sciences reports Q4 earnings per share $0.87

* Usana Health Sciences reports fourth quarter and full-year financial results

BRIEF-USANA Health Sciences Inc says company will no longer utilize a co-CEO management structure

* USANA Health Sciences Inc says company will no longer utilize a co-CEO management structure

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up